Skip to content
Thymidine
Zalmoxis (thymidine) is a small molecule pharmaceutical. Thymidine was first approved as Zalmoxis on 2016-08-18. It has been approved in Europe to treat graft vs host disease and hematopoietic stem cell transplantation.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
immune system diseasesD007154
therapeuticsD013812
operative surgical proceduresD013514
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
13 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50——1—12
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD002289—1——23
Liver neoplasmsD008113EFO_1001513C22.011———2
Ovarian neoplasmsD010051EFO_0003893C56—1———1
Fallopian tube neoplasmsD005185—1———1
Mitochondrial diseasesD028361EFO_0000591—1———1
Mitochondrial encephalomyopathiesD017237—1———1
Liver transplantationD016031EFO_0010682—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C801————1
Tetralogy of fallotD013771Q21.31————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Triple negative breast neoplasmsD064726————11
Esophageal neoplasmsD004938C15————11
Healthy volunteers/patients—————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTHYMIDINE
INNdoxribtimine
Description
Thymidine is a pyrimidine 2'-deoxyribonucleoside having thymine as the nucleobase. It has a role as a metabolite, a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is functionally related to a thymine. It is an enantiomer of a telbivudine.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O
Identifiers
PDB—
CAS-ID50-89-5
RxCUI1372538
ChEMBL IDCHEMBL52609
ChEBI ID17748
PubChem CID5789
DrugBankDB04485
UNII IDVC2W18DGKR (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 122,594 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details